| # | Drug | Count |
|---|---|---|
| 0 | AMIFAMPRIDINE PHOSPHATE | 163 |
| 1 | PREDNISONE | 85 |
| 2 | NIVOLUMAB | 80 |
| 3 | PYRIDOSTIGMINE BROMIDE | 80 |
| 4 | ASPIRIN | 64 |
| 5 | CARBOPLATIN | 64 |
| 6 | ASPIRIN 81 MG | 62 |
| 7 | ASPIRIN 325 MG | 61 |
| 8 | GABAPENTIN | 43 |
| 9 | IPILIMUMAB | 41 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIFAMPRIDINE PHOSPHATE | 163 | 0.0550 |
| 1 | PYRIDOSTIGMINE BROMIDE | 80 | 0.0105 |
| 2 | PYRIDOSTIGMINE BROMIDE ORAL | 36 | 0.0101 |
| 3 | GUAIFENESIN AND CODEINE PHOSPHATE | 1 | 0.0075 |
| 4 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 5 | NIVOLUMAB AND RELATLIMAB-RMBW | 2 | 0.0039 |
| 6 | REPOTRECTINIB | 1 | 0.0036 |
| 7 | CHLOROQUINE PHOSPHATE | 2 | 0.0030 |
| 8 | TIOPRONIN | 6 | 0.0024 |
| 9 | ASIAN GINSENG | 1 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 118 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 99 |
| 2 | Platinum-based Drug [EPC] | 82 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 82 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 65 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 46 |
| 6 | Proton Pump Inhibitor [EPC] | 39 |
| 7 | Vitamin C [EPC] | 39 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 38 |
| 9 | Benzodiazepine [EPC] | 36 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 2 | 0.0039 |
| 1 | Reducing and Complexing Thiol [EPC] | 6 | 0.0024 |
| 2 | Human Immunoglobulin G [EPC] | 33 | 0.0016 |
| 3 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 46 | 0.0010 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 82 | 0.0008 |
| 6 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 7 | Allylamine Antifungal [EPC] | 5 | 0.0007 |
| 8 | Vitamin D3 Analog [EPC] | 11 | 0.0005 |
| 9 | Carbonic Anhydrase Inhibitor [EPC] | 10 | 0.0005 |